February 11, 2020 / 12:43 PM / 8 days ago

BRIEF-Palatin Technologies Q2 Loss Per Share $0.02

Palatin Technologies Inc:

* PALATIN TECHNOLOGIES, INC. REPORTS SECOND QUARTER FISCAL YEAR 2020 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

* DRY EYE DISEASE PHASE 2 STUDY TO COMMENCE Q1 2020

* PALATIN TECHNOLOGIES- AMAG’S PLANNED DIVESTITURE OF VYLEESI IS BASED ON CHANGE IN STRATEGY, “AND IS NOT A RESULT OF VYLEESI LAUNCH PERFORMANCE TO DATE”

* PALATIN TECHNOLOGIES - DATA FROM DRY EYE DISEASE PHASE 2 STUDY EXPECTED IN Q4 2020 & ULCERATIVE COLITIS TRIAL DATA EXPECTED IN MID-CALENDAR YEAR 2021

* QTRLY LICENSE AND CONTRACT REVENUE $20,610 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below